Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and Mission Bay Capital BioLabs ("MBC BioLabs"), a life-science incubator, today...
Artisan Bio, a world-leader in CRISPR genome engineering technology, announced the launch of its CRISPR-based 1-stop shop developed from the company's proprietary STAR-CRISPR platform....
Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value...
Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, announced that its human induced pluripotent...
Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, announced the signing of a Memorandum of Understanding (MOU) with Merck Korea,...
